Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001947908 | SCV002187962 | uncertain significance | Autosomal recessive limb-girdle muscular dystrophy type R18 | 2022-08-31 | criteria provided, single submitter | clinical testing | This sequence change replaces leucine, which is neutral and non-polar, with phenylalanine, which is neutral and non-polar, at codon 917 of the TRAPPC11 protein (p.Leu917Phe). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 1416483). This variant has not been reported in the literature in individuals affected with TRAPPC11-related conditions. This variant is present in population databases (rs554771345, gnomAD 0.007%). |
Ambry Genetics | RCV002557735 | SCV003632822 | uncertain significance | Inborn genetic diseases | 2022-07-21 | criteria provided, single submitter | clinical testing | The c.2749C>T (p.L917F) alteration is located in exon 25 (coding exon 24) of the TRAPPC11 gene. This alteration results from a C to T substitution at nucleotide position 2749, causing the leucine (L) at amino acid position 917 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |